Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[Bibenzyl from Dendrobium inhibits angiogenesis and its underlying mechanism].

Gong CY, Lu B, Yang L, Wang L, Ji LL.

Yao Xue Xue Bao. 2013 Mar;48(3):337-42. Chinese.

PMID:
23724644
2.

Moscatilin, a bibenzyl derivative from the India orchid Dendrobrium loddigesii, suppresses tumor angiogenesis and growth in vitro and in vivo.

Tsai AC, Pan SL, Liao CH, Guh JH, Wang SW, Sun HL, Liu YN, Chen CC, Shen CC, Chang YL, Teng CM.

Cancer Lett. 2010 Jun 28;292(2):163-70. doi: 10.1016/j.canlet.2009.11.020. Epub 2009 Dec 28.

PMID:
20056528
3.

Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M.

Cancer Res. 2009 Jul 15;69(14):5893-900. doi: 10.1158/0008-5472.CAN-09-0755. Epub 2009 Jun 30.

4.

Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.

Huang SW, Lien JC, Kuo SC, Huang TF.

Carcinogenesis. 2012 May;33(5):1022-30. doi: 10.1093/carcin/bgs127. Epub 2012 Mar 20.

PMID:
22436611
5.

Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo.

Saraswati S, Agrawal SS.

Cancer Lett. 2013 May 10;332(1):83-93. doi: 10.1016/j.canlet.2013.01.012. Epub 2013 Jan 21.

PMID:
23348691
6.

c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.

Shen K, Ji L, Lu B, Wang Z.

Cell Biochem Biophys. 2012 Sep;64(1):17-27. doi: 10.1007/s12013-012-9363-0.

PMID:
22592917
7.

Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.

Tan WF, Zhang XW, Li MH, Yue JM, Chen Y, Lin LP, Ding J.

Eur J Pharmacol. 2004 Sep 24;499(3):219-28.

PMID:
15381043
8.

Deltonin inhibits angiogenesis by regulating VEGFR2 and subsequent signaling pathways in endothelial cells.

Tong Q, Zhao Q, Qing Y, Hu X, Jiang L, Wu X.

Steroids. 2015 Apr;96:30-6. doi: 10.1016/j.steroids.2014.12.019. Epub 2014 Dec 30.

PMID:
25554580
9.

Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation.

Mu X, Shi W, Sun L, Li H, Jiang Z, Zhang L.

Molecules. 2012 Jun 5;17(6):6854-68. doi: 10.3390/molecules17066854.

10.

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.

Gao F, Vasquez SX, Su F, Roberts S, Shah N, Grijalva V, Imaizumi S, Chattopadhyay A, Ganapathy E, Meriwether D, Johnston B, Anantharamaiah GM, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R.

Integr Biol (Camb). 2011 Apr;3(4):479-89. doi: 10.1039/c0ib00147c. Epub 2011 Feb 1.

11.

Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.

Tong Q, Qing Y, Wu Y, Hu X, Jiang L, Wu X.

Toxicol Appl Pharmacol. 2014 Dec 1;281(2):166-73. doi: 10.1016/j.taap.2014.07.026. Epub 2014 Aug 8.

PMID:
25111127
12.

The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.

Watari K, Nakamura M, Fukunaga Y, Furuno A, Shibata T, Kawahara A, Hosoi F, Kuwano T, Kuwano M, Ono M.

Int J Cancer. 2012 Jul 15;131(2):310-21. doi: 10.1002/ijc.26356. Epub 2011 Sep 14.

13.
14.

Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.

Zhang L, Ji Q, Liu X, Chen X, Chen Z, Qiu Y, Sun J, Cai J, Zhu H, Li Q.

Cancer Sci. 2013 May;104(5):604-10. doi: 10.1111/cas.12120. Epub 2013 Mar 20.

15.

Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.

Zhong ZF, Hoi PM, Wu GS, Xu ZT, Tan W, Chen XP, Cui L, Wu T, Wang YT.

J Ethnopharmacol. 2012 Jun 1;141(2):721-7. doi: 10.1016/j.jep.2011.08.052. Epub 2011 Sep 3.

PMID:
21911050
16.

Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation.

Kwak HJ, Park MJ, Park CM, Moon SI, Yoo DH, Lee HC, Lee SH, Kim MS, Lee HW, Shin WS, Park IC, Rhee CH, Hong SI.

Int J Cancer. 2006 Jun 1;118(11):2711-20.

17.

The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.

Chuang IC, Yang CM, Song TY, Yang NC, Hu ML.

Life Sci. 2015 Oct 15;139:52-61. doi: 10.1016/j.lfs.2015.08.002. Epub 2015 Aug 15.

PMID:
26285173
18.

Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.

Huang W, Liang Y, Wang J, Li G, Wang G, Li Y, Chung HY.

Phytomedicine. 2016 Mar 15;23(3):283-92. doi: 10.1016/j.phymed.2015.12.021. Epub 2016 Jan 29.

PMID:
26969382
19.

Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.

Awasthi N, Schwarz MA, Verma V, Cappiello C, Schwarz RE.

Lab Invest. 2009 Jan;89(1):38-46. doi: 10.1038/labinvest.2008.106. Epub 2008 Nov 10.

20.

Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.

Buharalioglu CK, Song CY, Yaghini FA, Ghafoor HU, Motiwala M, Adris T, Estes AM, Malik KU.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H1043-55. doi: 10.1152/ajpheart.01018.2010. Epub 2011 Jun 3.

Supplemental Content

Support Center